Eribulin Baxter

eribulin mesylate · Baxter Holding B.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Eribulin Baxter, covering 2026-02-24 to 2026-02-24. Get the full timeline:

Most recent: EMA Authorised: Eribulin Baxter (Eribulin mesylate) — Baxter Holding B.V.